Publications by authors named "Colin Flaveny"

Claim this Profile
A
A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
Monideepa Sengupta, Suomia Abuirqeba, Amina Kameric, Aurore Cecile-Valfort, Arindam Chatterjee, Colin A Flaveny

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined regenerative rehabilitation improves recovery following volumetric muscle loss injury in a rat model.
David Johnson, Connor Tobo, Jeffrey Au, Aakash Nagarapu, Natalia Ziemkiewicz, Colin A Flaveny

J Biomed Mater Res B Appl Biomater· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.
Thomas P Burris, Ian Mitchelle S de Vera, Isabelle Cote, Colin A Flaveny, Udayanga S Wanninayake

Pharmacol Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT1 Drives the Interferon-Like Response and Aging Hallmarks in Progeria.
Rafael Cancado de Faria, Elena V Shashkova, Colin Flaveny, Angel Baldan, Kyle S McCommis

Aging Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal Degeneration: Short-Term Options and Long-Term Vision for Future Therapy.
Shabnam Majidi, Judith M Ogilvie, Colin A Flaveny

Mo Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition.
Adele M Musicant, Kshitij Parag-Sharma, Weida Gong, Monideepa Sengupta, Arindam Chatterjee, Colin A Flaveny

Cell Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice.
Ryan D Welch, Cyrielle Billon, Amina Kameric, Thomas P Burris, Colin A Flaveny

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer.
Katherine J Carpenter, Aurore-Cecile Valfort, Nick Steinauer, Arindam Chatterjee, Suomia Abuirqeba, Colin A Flaveny

Sci Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract.
Subhayan Sur, Hiroshi Nakanishi, Colin Flaveny, Joseph E Ippolito, Jane McHowat

Cell Commun Signal· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract.
Subhayan Sur, Hiroshi Nakanishi, Colin Flaveny, Joseph E Ippolito, Jane McHowat

Cell Commun Signal· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver Disease.
Monideepa Sengupta, Kristine Griffett, Colin A Flaveny, Thomas P Burris

ACS Pharmacol Transl Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle.
Ryan D Welch, Cyrielle Billon, Aurore-Cecile Valfort, Thomas P Burris, Colin A Flaveny

Sci Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome.
Ryan D Welch, Chun Guo, Monideepa Sengupta, Katherine J Carpenter, Natalie A Stephens, Colin A Flaveny

Mol Metab· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REV-ERB and ROR: therapeutic targets for treating myopathies.
Ryan D Welch, Colin A Flaveny

Phys Biol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.
Franz X Schaub, Md Shamim Reza, Colin A Flaveny, Weimin Li, Adele M Musicant

Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.
Bin Li, Colin A Flaveny, Camilla Giambelli, Dennis Liang Fei, Lu Han

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis.
Colin A Flaveny, Kristine Griffett, Bahaa El-Dien M El-Gendy, Melissa Kazantzis, Monideepa Sengupta

Cancer Cell· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis.
Kristine Griffett, Ryan D Welch, Colin A Flaveny, Grant R Kolar, Brent A Neuschwander-Tetri

Mol Metab· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrvinium attenuates Hedgehog signaling downstream of smoothened.
Bin Li, Dennis Liang Fei, Colin A Flaveny, Nadia Dahmane, Valérie Baubet

Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hedgehog signaling regulates bladder cancer growth and tumorigenicity.
Dennis Liang Fei, Avencia Sanchez-Mejias, Zhiqiang Wang, Colin Flaveny, Jun Long

Cancer Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavone.
Iain A Murray, Colin A Flaveny, Christopher R Chiaro, Arun K Sharma, Rachel S Tanos

Mol Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.
Anthony E Boitano, Jian Wang, Russell Romeo, Laure C Bouchez, Albert E Parker, Colin A Flaveny

Science· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.
Brett C DiNatale, Iain A Murray, Jennifer C Schroeder, Colin A Flaveny, Tejas S Lahoti

Toxicol Sci· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties.
Iain A Murray, Gowdahalli Krishnegowda, Brett C DiNatale, Colin Flaveny, Chris Chiaro

Chem Res Toxicol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential gene regulation by the human and mouse aryl hydrocarbon receptor.
Colin A Flaveny, Iain A Murray, Gary H Perdew

Toxicol Sci· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis